LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Foresite Capital Management IV, LLC's Holding History (CIK: 0001704132)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 16,007,999 Value ($000) $8,612 Avg Close — Range —
Q4 2024
Shares 8,325,000 Value ($000) $5,328 Avg Close — Range —
Q3 2024
Shares 8,325,000 Value ($000) $11,489 Avg Close — Range —
Q2 2024
Shares 8,325,000 Value ($000) $12,071 Avg Close — Range —
Q1 2024
Shares 8,325,000 Value ($000) $18,565 Avg Close — Range —
Q4 2023
Shares 8,325,000 Value ($000) $16,151 Avg Close — Range —
Q3 2023
Shares 8,784,813 Value ($000) $12,914 Avg Close — Range —
Q2 2023
Shares 9,700,000 Value ($000) $30,846 Avg Close — Range —
Q1 2023
Shares 10,000,000 Value ($000) $23,600 Avg Close — Range —
Q4 2022
Shares 10,000,000 Value ($000) $34,700 Avg Close — Range —
Q3 2022
Shares 10,000,000 Value ($000) $73,300 Avg Close — Range —
Q2 2022
Shares 13,282,181 Value ($000) $86,600 Avg Close — Range —
Q1 2022
Shares 13,282,181 Value ($000) $67,075 Avg Close — Range —
Q4 2021
Shares 13,282,181 Value ($000) $102,804 Avg Close — Range —
Q3 2021
Shares 13,282,181 Value ($000) $196,576 Avg Close — Range —
Q2 2021
Shares 13,282,181 Value ($000) $215,703 Avg Close — Range —